A small group of people with Parkinson's disease had been pleading for months with the biotechnology company Amgen: Let them resume taking an experimental drug that the patients said had helped them but which the company said was ineffective and possibly dangerous.
A new robotic microscope that follows a brain cell in the lab from a normal state to its death has led researchers to a surprising finding that appears to debunk a long-standing theory about Huntington's disease.
